Showing results (2061-2070 of 2,138) with videos related to

Sort By:
Pageof 214
European Journal of Cancer (Oxford, England : 1990)|January 15, 2023
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancerPaolo Nuciforo, John Townend, Martine J Piccart, et al.
The New England Journal of Medicine|March 12, 2004
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancerR Charles Coombes, Emma Hall, Lorna J Gibson, et al.
Frontiers in Immunology|December 8, 2017
Safety and Immunogenicity of Malaria Vectored Vaccines Given with Routine Expanded Program on Immunization Vaccines in Gambian Infants and Neonates: A Randomized Controlled TrialVictorine A Mensah, Sophie Roetynck, Ebrima K Kanteh, et al.
Plos One|February 1, 2017
Zika Virus Tissue and Blood Compartmentalization in Acute Infection of Rhesus MacaquesLark L Coffey, Patricia A Pesavento, Rebekah I Keesler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 23, 2022
Everolimus Added to Adjuvant Endocrine Therapy in Patients With High-Risk Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Primary Breast CancerThomas Bachelot, Paul Cottu, Sylvie Chabaud, et al.
Viruses|September 28, 2021
Neonatal Development in Prenatally Zika Virus-Exposed Infant Macaques with Dengue ImmunityKarla Ausderau, Sabrina Kabakov, Elaina Razo, et al.
NEJM Evidence|July 22, 2025
Contraceptive Efficacy and Comparative Side Effects of a Mini Copper Intrauterine DeviceCourtney A Schreiber, Kavita Nanda, David Hubacher, et al.
Antimicrobial Agents and Chemotherapy|March 13, 2024
Opportunistic dried blood spot sampling validates and optimizes a pediatric population pharmacokinetic model of metronidazoleRachel L Randell, Stephen J Balevic, Rachel G Greenberg, et al.
Lancet (London, England)|June 11, 2023
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trialCharlotte E Coles, Joanne S Haviland, Anna M Kirby, et al.
Contraception|July 31, 2026
Comparing the TCu380A and a small Nova-T copper IUD: secondary analysis of discontinuation probabilities, bleeding outcomes and satisfaction in nulliparous participants from a 3-year randomized trialDavid Hubacher, Courtney A Schreiber, David K Turok, et al.
Pageof 214